Clinical trials recruiting for Chronic Liver Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Heplisav-B Injectable Product, 2-dose regimen | 1 |
| Heplisav-B Injectable Product, 3-dose regimen | 1 |
| LAENNEC (Human Placenta Hydrolysate) IV | 1 |
| LAENNEC (Human Placenta Hydrolysate) SC | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 1 |
Top cities
Self-screener
Recruiting trials
- An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
- Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
- D-SOLVE Cohorts (Cohort a and B)
- In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
- Nottingham Community Liver Biomarkers Cohort
- hepatomiR cACLD Study
Related conditions
Trials recruiting for Chronic Liver Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chronic Liver Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.